Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen I Shibata

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 30, 2009
Blepharoptosis following oxaliplatin administrationS Cecilia Lau, Stephen I Shibata
Cancer Chemotherapy and Pharmacology|May 29, 2013
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumorsSyma Iqbal, Heinz-Josef Lenz, David R Gandara, et al.
American Journal of Clinical Oncology|February 11, 2003
Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysisRoderich E Schwarz, David D Smith, Hemant Keny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
American Journal of Clinical Oncology|October 11, 2008
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium TrialY Yen, Dean W Lim, Vincent Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 30, 2009
Blepharoptosis following oxaliplatin administrationS Cecilia Lau, Stephen I Shibata
Cancer Chemotherapy and Pharmacology|May 29, 2013
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumorsSyma Iqbal, Heinz-Josef Lenz, David R Gandara, et al.
American Journal of Clinical Oncology|February 11, 2003
Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysisRoderich E Schwarz, David D Smith, Hemant Keny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
American Journal of Clinical Oncology|October 11, 2008
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium TrialY Yen, Dean W Lim, Vincent Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
Pageof 1